Literature DB >> 8592003

S100 protein CP-10 stimulates myeloid cell chemotaxis without activation.

C J Cornish1, J M Devery, P Poronnik, M Lackmann, D I Cook, C L Geczy.   

Abstract

Leukocyte recruitment to inflammatory foci is generally associated with cellular activation. Recent evidence suggests that chemotactic agents can be divided into two classes, "classical chemoattractants" such as FMLP, C5a, and IL-8, which stimulate directed migration and activation events and "pure chemoattractants" such as TGF-beta 1 which influence actin polymerisation and movement but not oxidative burst and associated granular enzyme release. The studies reported here demonstrate that the murine S100 chemoattractant protein, CP-10, belongs to the "non-classical" group. Despite its potent chemotactic activity for neutrophils and monocytes/macrophages, CP-10 failed to increase [Ca2+]i in human or mouse PMN, although chemotaxis was inhibited by pertussis toxin, confirming the suggestion of a novel Ca(2+)-independent G-protein-coupled pathway for post-receptor signal transduction triggered by "pure chemoattractants." The co-ordinated up-regulation of Mac-1 and down-regulation of L-selectin induced by FMLP on human PMN in vitro was not observed with CP-10. Quantitative changes in immediate (30 s) actin polymerisation occurred with FMLP and CP-10-treated human PMN. The relative F-actin increases induced in WEHI 265 monocytoid cells by FMLP and CP-10 was optimal at 60 s and declined over 120 s. F-actin changes reflected the concentration and potencies of the agonists required to provoke chemotaxis. After 90 min, CP-10 profoundly altered cell shape and increased both cell size and F-actin within pseudopodia. These changes are typical of those mediating leukocyte deformability, and CP-10 may mediate leukocyte retention within microcapillaries and thereby contribute to the initiation of inflammation in vascular beds.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8592003     DOI: 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  27 in total

1.  ANTI-INFECTIVE PROTECTIVE PROPERTIES OF S100 CALGRANULINS.

Authors:  Kenneth Hsu; Chantrakorn Champaiboon; Brian D Guenther; Brent S Sorenson; Ali Khammanivong; Karen F Ross; Carolyn L Geczy; Mark C Herzberg
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-12-04

2.  The middle ear immune defense changes with age.

Authors:  Michelle Christine Nielsen; Morten Friis; Tomas Martin-Bertelsen; Ole Winther; Lennart Friis-Hansen; Per Cayé-Thomasen
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-07       Impact factor: 2.503

3.  S100 Proteins in the Innate Immune Response to Pathogens.

Authors:  Natalia Kozlyuk; Andrew J Monteith; Velia Garcia; Steven M Damo; Eric P Skaar; Walter J Chazin
Journal:  Methods Mol Biol       Date:  2019

4.  S100A8 triggers oxidation-sensitive repulsion of neutrophils.

Authors:  H Y Sroussi; J Berline; P Dazin; P Green; J M Palefsky
Journal:  J Dent Res       Date:  2006-09       Impact factor: 6.116

5.  Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis.

Authors:  David D Tieu; Anju T Peters; Roderick G Carter; Roderick T Carter; Lydia Suh; David B Conley; Rakesh Chandra; James Norton; Leslie C Grammer; Kathleen E Harris; Atsushi Kato; Robert C Kern; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2010-03       Impact factor: 10.793

6.  S100A8/A9 is not involved in host defense against murine urinary tract infection.

Authors:  Mark C Dessing; Loes M Butter; Gwendoline J Teske; Nike Claessen; Chris M van der Loos; Thomas Vogl; Johannes Roth; Tom van der Poll; Sandrine Florquin; Jaklien C Leemans
Journal:  PLoS One       Date:  2010-10-14       Impact factor: 3.240

Review 7.  The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease.

Authors:  Jennifer C Brazil; Nancy A Louis; Charles A Parkos
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

Review 8.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

9.  Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.

Authors:  Ronald Wolf; O M Zack Howard; Hui-Fang Dong; Christopher Voscopoulos; Karen Boeshans; Jason Winston; Rao Divi; Michele Gunsior; Paul Goldsmith; Bijan Ahvazi; Triantafyllos Chavakis; Joost J Oppenheim; Stuart H Yuspa
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

10.  S100A8 and S100A9 in experimental osteoarthritis.

Authors:  Hala Zreiqat; Daniele Belluoccio; Margaret M Smith; Richard Wilson; Lynn A Rowley; Katie Jones; Yogambha Ramaswamy; Thomas Vogl; Johannes Roth; John F Bateman; Christopher B Little
Journal:  Arthritis Res Ther       Date:  2010-01-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.